The regulation of cancer cell death and metabolism by extracellular matrix attachment

Seminars in Cell and Developmental Biology

Volumn 23, Issue 4, 2012, Pages 402-411

  Buchheit, Cassandra L ^a   Rayavarapu, Raju R ^a   Schafer, Zachary T ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Anoikis; Cancer metabolism; Cell death; Extracellular matrix; Metastasis; Reactive oxygen species

Indexed keywords

ANGIOPOIETIN; B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOSE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMINE; GLYCOGEN PHOSPHORYLASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PYRUVATE DEHYDROGENASE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN 140; TRANSCRIPTION FACTOR NRF2; TRICARBOXYLIC ACID;

ANOIKIS; ANTIOXIDANT ACTIVITY; AUTOPHAGY; CANCER CELL; CANCER RESISTANCE; CARCINOGENICITY; CELL ADHESION; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; CELL TYPE; CELL VIABILITY; CITRIC ACID CYCLE; ENTOSIS; EXTRACELLULAR MATRIX; FATTY ACID OXIDATION; GENE TARGETING; HUMAN; HYPOXIA; MOLECULAR MECHANICS; NECROPTOSIS; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84861982020     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.04.007     Document Type: Review

References (94)

1. Nguyen D.X., Massague J. Genetic determinants of cancer metastasis. Nature Reviews Genetics 2007, 8:341-352.
2. Mina L.A., Sledge G.W. Rethinking the metastatic cascade as a therapeutic target. Nature Reviews Clinical Oncology 2011, 8:325-332.
3. Smith S.C., Theodorescu D. Learning therapeutic lessons from metastasis suppressor proteins. Nature Reviews Cancer 2009, 9:253-264.
4. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Developmental Cell 2008, 14:818-829.
5. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
6. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nature Reviews Cancer 2009, 9:239-252.
7. Simpson C.D., Anyiwe K., Schimmer A.D. Anoikis resistance and tumor metastasis. Cancer Letters 2008, 272:177-185.
8. Frisch S.M., Screaton R.A. Anoikis mechanisms. Current Opinion in Cell Biology 2001, 13:555-562.
9. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. Journal of Cell Biology 1994, 124:619-626.
10. Meredith J.E., Fazeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Molecular Biology of the Cell 1993, 4:953-961.
11. Horbinski C., Mojesky C., Kyprianou N. Live free or die: tales of homeless (cells) in cancer. American Journal of Pathology 2010, 177:1044-1052.
12. Overholtzer M., Mailleux A.A., Mouneimne G., Normand G., Schnitt S.J., King R.W., et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007, 131:966-979.
13. Fung C., Lock R., Gao S., Salas E., Debnath J. Induction of autophagy during extracellular matrix detachment promotes cell survival. Molecular Biology of the Cell 2008, 19:797-806.
14. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
15. Galluzzi L., Morselli E., Vicencio J.M., Kepp O., Joza N., Tajeddine N., et al. Life, death and burial: multifaceted impact of autophagy. Biochemical Society Transactions 2008, 36:786-790.
16. Schafer Z.T., Grassian A.R., Song L., Jiang Z., Gerhart-Hines Z., Irie H.Y., et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.
17. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
18. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
19. Grassian A.R., Metallo C.M., Coloff J.L., Stephanopoulos G., Brugge J.S. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes and Development 2011, 25:1716-1733.
20. Kamarajugadda S., Stemboroski L., Cai Q., Simpson N.E., Nayak S., Tan M., et al. Glucose oxidation modulates anoikis and tumor metastasis. Molecular and Cellular Biology 2012.
21. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes and Development 1999, 13:76-86.
22. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nature Genetics 2003, 35:238-245.
23. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 1997, 236:313-322.
24. 2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011, 19:401-415.
25. Warburg O., Posener K., Negelein E. Ueber den stoffwechsel der tumoren. Biochemische Zeitschrift 1924, 152:319-344.
26. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
27. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
28. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
29. Bensinger S.J., Christofk H.R. New aspects of the Warburg effect in cancer cell biology. Seminars in Cell and Developmental Biology 2012.
30. Steinberg P., Klingelhoffer A., Schafer A., Wust G., Weisse G., Oesch F., et al. Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Archiv 1999, 434:213-220.
31. Domingo M., Einig C., Eigenbrodt E., Reinacher M. Immunohistological demonstration of pyruvate kinase isoenzyme type L in rat with monoclonal antibodies. Journal of Histochemistry and Cytochemistry 1992, 40:665-673.
32. Brinck U., Eigenbrodt E., Oehmke M., Mazurek S., Fischer G. L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases. Virchows Archiv 1994, 424:177-185.
33. Rodriguez-Horche P., Luque J., Perez-Artes E., Pineda M., Pinilla M. Comparative kinetic behaviour and regulation by fructose-1,6-bisphosphate and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells. Comparative Biochemistry and Physiology B: Comparative Biochemistry 1987, 87:553-557.
34. Noguchi T., Inoue H., Tanaka T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. Journal of Biological Chemistry 1986, 261:13807-13812.
35. Yamada K., Noguchi T. Regulation of pyruvate kinase M gene expression. Biochemical and Biophysical Research Communications 1999, 256:257-262.
36. Reinacher M., Eigenbrodt E., Schering B., Schoner W. Immunohistochemical localization of pyruvate kinase isoenzymes in chicken tissues. Histochemistry 1979, 64:145-161.
37. Carbonell J., Feliu J.E., Marco R., Sols A. Pyruvate kinase. Classes of regulatory isoenzymes in mammalian tissues. European Journal of Biochemistry 1973, 37:148-156.
38. Reinacher M., Eigenbrodt E. Immunohistological demonstration of the same type of pyruvate kinase isoenzyme (M2-Pk) in tumors of chicken and rat. Virchows Archiv B, Cell Pathology Including Molecular Pathology 1981, 37:79-88.
39. Staal G.E., Rijksen G. The role of red cell aging in the diagnosis of glycolytic enzyme defects. Advances in Experimental Medicine and Biology 1991, 307:239-249.
40. Hitosugi T., Kang S., Vander Heiden M.G., Chung T.W., Elf S., Lythgoe K., et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Science Signaling 2009, 2:ra73.
41. Vander Heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
42. Tamada M., Nagano O., Tateyama S., Ohmura M., Yae T., Ishimoto T., et al. Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells. Cancer Research 2012, 72:1438-1448.
43. Gruning N.M., Rinnerthaler M., Bluemlein K., Mulleder M., Wamelink M.M., Lehrach H., et al. Pyruvate kinase triggers a metabolic feedback loop that controls redox metabolism in respiring cells. Cell Metabolism 2011, 14:415-427.
44. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
45. Locasale J.W., Cantley L.C. Altered metabolism in cancer. BMC Biology 2010, 8:88.
46. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
47. Jung C.H., Ro S.H., Cao J., Otto N.M., Kim D.H. mTOR regulation of autophagy. FEBS Letters 2010, 584:1287-1295.
48. Chang Y.Y., Juhasz G., Goraksha-Hicks P., Arsham A.M., Mallin D.R., Muller L.K., et al. Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochemical Society Transactions 2009, 37:232-236.
49. Bensaad K., Cheung E.C., Vousden K.H. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO Journal 2009, 28:3015-3026.
50. Budanov A.V., Karin M. p53 target genes sestrin 1 and sestrin 2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
51. Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y., et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Molecular Cell 2005, 18:283-293.
52. Bungard D., Fuerth B.J., Zeng P.Y., Faubert B., Maas N.L., Viollet B., et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 2010, 329:1201-1205.
53. Ng T.L., Leprivier G., Robertson M.D., Chow C., Martin M.J., Laderoute K.R., et al. The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis. Cell Death and Differentiation 2011, 19:501-510.
54. Generali D., Berruti A., Brizzi M.P., Campo L., Bonardi S., Wigfield S., et al. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clinical Cancer Research 2006, 12:4562-4568.
55. Bos R., Zhong H., Hanrahan C.F., Mommers E.C., Semenza G.L., Pinedo H.M., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. Journal of the National Cancer Institute 2001, 93:309-314.
56. Rohwer N., Welzel M., Daskalow K., Pfander D., Wiedenmann B., Detjen K., et al. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Research 2008, 68:10113-10120.
57. Shen W., Chen D., Fu H., Liu S., Sun K., Sun X. S100A4 protects gastric cancer cells from anoikis through regulation of alphav and alpha5 integrin. Cancer Science 2011, 102:1014-1018.
58. Reginato M.J., Mills K.R., Becker E.B., Lynch D.K., Bonni A., Muthuswamy S.K., et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Molecular and Cellular Biology 2005, 25:4591-4601.
59. Schmelzle T., Mailleux A.A., Overholtzer M., Carroll J.S., Solimini N.L., Lightcap E.S., et al. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:3787-3792.
60. Whelan K.A., Caldwell S.A., Shahriari K.S., Jackson S.R., Franchetti L.D., Johannes G.J., et al. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Molecular Biology of the Cell 2010, 21:3829-3837.
61. Whelan K.A., Reginato M.J. Surviving without oxygen: hypoxia regulation of mammary morphogenesis and anoikis. Cell Cycle 2011, 10:2287-2294.
62. Lock R., Debnath J. Extracellular matrix regulation of autophagy. Current Opinion in Cell Biology 2008, 20:583-588.
63. Tsuchihara K., Fujii S., Esumi H. Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Letters 2009, 278:130-138.
64. Debnath J., Mills K.R., Collins N.L., Reginato M.J., Muthuswamy S.K., Brugge J.S. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002, 111:29-40.
65. Mirzoeva O.K., Hann B., Hom Y.K., Debnath J., Aftab D., Shokat K., et al. Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI(3)K-mTOR pathway in pancreatic adenocarcinoma. Journal of Molecular Medicine (Berlin) 2011, 89:877-889.
66. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of ULK1. Nature Cell Biology 2011, 13:132-141.
67. Avivar-Valderas A., Salas E., Bobrovnikova-Marjon E., Diehl J.A., Nagi C., Debnath J., et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Molecular and Cellular Biology 2011, 31:3616-3629.
68. Fels D.R., Koumenis C. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biology and Therapy 2006, 5:723-728.
69. Overholtzer M., Brugge J.S. The cell biology of cell-in-cell structures. Nature Reviews Molecular Cell Biology 2008, 9:796-809.
70. Florey O., Kim S.E., Sandoval C.P., Haynes C.M., Overholtzer M. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nature Cell Biology 2011, 13:1335-1343.
71. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., Mizushima N., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chemical Biology 2005, 1:112-119.
72. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., Xavier R.J., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
73. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., Teng X., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nature Chemical Biology 2008, 4:313-321.
74. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
75. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Molecular Cell 2006, 22:245-257.
76. Wang L., Du F., Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
77. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., Lin S.C., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
78. He S., Wang L., Miao L., Wang T., Du F., Zhao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
79. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., Guildford M., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
80. Sun L., Wang H., Wang Z., He S., Chen S., Liao D., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
81. Wang Z., Jiang H., Chen S., Du F., Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148:228-243.
82. Lo S.C., Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Experimental Cell Research 2008, 314:1789-1803.
83. Bunney T.D., Katan M. Phosphoinositide signalling in cancer: beyond PI(3)K and PTEN. Nature Reviews Cancer 2010, 10:342-352.
84. Engelman J.A. Targeting PI(3)K signalling in cancer: opportunities, challenges and limitations. Nature Reviews Cancer 2009, 9:550-562.
85. Jiang B.H., Liu L.Z. PI(3)K/PTEN signaling in angiogenesis and tumorigenesis. Advances in Cancer Research 2009, 102:19-65.
86. Wellen K.E., Thompson C.B. A two-way street: reciprocal regulation of metabolism and signalling. Nature Reviews Molecular Cell Biology 2012, 13:270-276.
87. Weihua Z., Tsan R., Huang W.C., Wu Q., Chiu C.H., Fidler I.J., et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008, 13:385-393.
88. Geiger T.R., Peeper D.S. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective. Cancer Research 2005, 65:7033-7036.
89. Douma S., Van Laar T., Zevenhoven J., Meuwissen R., Van Garderen E., Peeper D.S. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004, 430:1034-1039.
90. Geiger T.R., Song J.Y., Rosado A., Peeper D.S. Functional characterization of human cancer-derived TRKB mutations. PLoS One 2011, 6:e16871.
91. Yu X., Liu L., Cai B., He Y., Wan X. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer. Cancer Science 2008, 99:543-552.
92. Lagadec C., Meignan S., Adriaenssens E., Foveau B., Vanhecke E., Romon R., et al. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene 2009, 28:1960-1970.
93. Jin W., Kim G.M., Kim M.S., Lim M.H., Yun C., Jeong J., et al. TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis 2010, 31:1939-1947.
94. Tong X., Zhao F., Thompson C.B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Current Opinion in Genetics and Development 2009, 19(1):32-37.